Bioretec (FRA:0TN) Total Liabilities: €1.92 Mil (As of Dec. 2025)


What is Bioretec Total Liabilities?

Bioretec FRA:0TN Total Liabilities is €1.92 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Bioretec's Total Liabilities for the quarter that ended in Dec. 2025 was €1.92 Mil.

Bioretec's quarterly Total Liabilities increased from Dec. 2024 (€1.74 Mil) to Jun. 2025 (€3.50 Mil) but then declined from Jun. 2025 (€3.50 Mil) to Dec. 2025 (€1.92 Mil).

Bioretec's annual Total Liabilities declined from Dec. 2023 (€2.43 Mil) to Dec. 2024 (€1.74 Mil) but then increased from Dec. 2024 (€1.74 Mil) to Dec. 2025 (€1.92 Mil).

Bioretec Total Liabilities Historical Data

* Premium members only.

The historical data trend for Bioretec's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioretec Total Liabilities Chart

Bioretec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 4.24 1.57 2.43 1.74 1.92

Bioretec Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.43 1.85 1.74 3.50 1.92

Bioretec Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bioretec's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.779+(0.138+1.1102230246252E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.92

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=11.679-9.762
=1.92

Bioretec's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.779+(0.138+1.1102230246252E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.92

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=11.679-9.762
=1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1.92 Mil mean?
Bioretec (FRA:0TN) has a Total Liabilities of €1.92 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bioretec and its competitors.
Is Bioretec's Total Liabilities too high?
Bioretec's current Total Liabilities is €1.92 Mil.
How does Bioretec's Total Liabilities compare to ABT and SYK?
Bioretec's Total Liabilities of €1.92 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bioretec and its competitors. Bioretec's current Total Liabilities is €1.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioretec stock overvalued right now?
Based on GuruFocus' analysis, Bioretec (FRA:0TN) is currently considered Possible Value Trap. The stock's GF Value™ is €0.18, compared to a current price of €0.02 — trading 88.9% below its estimated fair value. The current Total Liabilities is €1.92 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Bioretec (FRA:0TN), the current Total Liabilities is €1.92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioretec Business Description

Other Exchanges BRETEC:Finland
Address Yrittajankulma 5, Tampere, FIN, 33710
Bioretec Ltd is a medical device company focusing on the development of bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. It has developed the following product lines: RemeOs and Activa. RemeOs is based on a high-performance magnesium alloy and hybrid composite, introducing absorbable materials for enhanced surgical outcomes. The RemeOs implants (RemeOs Screw Lag, RemeOs Screw Lag Solid, RemeOs Screw FT, etc.) are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The Activa implants (ActivaPin, ActivaNail, ActivaScrew, etc.) are based on fully absorbable biopolymer products that facilitate natural bone healing without requiring removal surgery.